EMLA

This brand name is authorized in Austria, Brazil, Canada, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Japan, Malta, Mexico, Netherlands, New Zealand, Poland, Singapore, Tunisia, Turkey, United Kingdom, South Africa

Active ingredients

The drug EMLA contains a combination of these active pharmaceutical ingredients (APIs):

1 Lidocaine
UNII 98PI200987 - LIDOCAINE

Lidocaine, like other local anaesthetics, causes a reversible blockade of impulse propagation along nerve fibres by preventing the inward movement of sodium ions through the nerve membrane. Local anaesthetics of the amide-type are thought to act within the sodium channels of the nerve membrane.

Read about Lidocaine
2 Prilocaine
UNII 046O35D44R - PRILOCAINE

Prilocaine is a toluidine derivative and intermediate-acting amino amide with local anesthetic property. Prilocaine binds to the intracellular surface of sodium channels which blocks the subsequent influx of sodium into the cell. Action potential propagation and never function is, therefore, prevented. This block is reversible and when the drug diffuses away from the cell, sodium channel function is restored and nerve propagation returns.

Read about Prilocaine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
D04AB01 Lidocaine D Dermatologicals → D04 Antipruritics, incl. antihistamines, anesthetics, etc. → D04A Antipruritics, incl. antihistamines, anesthetics, etc. → D04AB Anesthetics for topical use
Discover more medicines within D04AB01
N01BB04 Prilocaine N Nervous system → N01 Anesthetics → N01B Anesthetics, local → N01BB Amides
Discover more medicines within N01BB04
N01BB20 Combinations N Nervous system → N01 Anesthetics → N01B Anesthetics, local → N01BB Amides
Discover more medicines within N01BB20

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 505618100044717, 505618100044817
Country: CA Health Products and Food Branch Identifier(s): 00886858, 02057794
Country: EE Ravimiamet Identifier(s): 1075306, 1151446, 1163843, 1257375, 1782301
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 61096
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 007784, 447300, 447557, 528869
Country: FR Base de données publique des médicaments Identifier(s): 63396602, 67458460
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 194666, 194667, 29374, 399390, 76684
Country: HK Department of Health Drug Office Identifier(s): 27892
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 2535
Country: JP 医薬品医療機器総合機構 Identifier(s): 1219800N1023, 1219800S1027
Country: MT Medicines Authority Identifier(s): MA955/01001, PI1438/05801A, PI908/15602A
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 120M98, 375M2002
Country: NL Z-Index G-Standaard, PRK Identifier(s): 25321, 39667
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 4617, 4618
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100021795, 100082578, 100255895, 100262990, 100289256, 100308893, 100334198, 100358342, 100372069, 100413584, 100425819, 100429591, 100436496, 100450889, 100453000, 100459723, 100468510
Country: SG Health Sciences Authority Identifier(s): 06443P
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 5103061
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699874080502
Country: ZA Health Products Regulatory Authority Identifier(s): 30/4/0478, Z/4/51

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.